Associate Professor of Pediatrics, Boston Children's Hospital
Pediatric Pulmonology
Dr. Henry L. Dorkin, MD
|
|
Give Review
Henry Dorkin works in the field of Pediatric Pulmonology. He attended Johns Hopkins University School of Medicine. Johns Hopkins University School of Medicine is a top medical university. Johns Hopkins University School of Medicine is ranked 3 in research and 29 in primary care medicine He received awards:"America's Top Doctors", "Boston Magazine", "Fellow (FAAP)", "Super Doctor" and "Top MD". Henry Dorkin is a published MD. He has 38 publications published. The most current publication "Increased nerve-growth-factor beta-chain cross-reacting material in familial dysautonomia." He accepts all Medicare patients.
Publications
- Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with Cystic fibrosis homozygous for the F508del-CFTR mutation.
- Repeated aerosolized AAV-CFTR for treatment of Cystic fibrosis: a randomized placebo-controlled phase 2B trial.
- Early pulmonary manifestation of Cystic fibrosis in children with the DeltaF508/R117H-7T genotype.
- Species-specific bacteria identification using differential mobility spectrometry and bioinformatics pattern recognition.
- Challenges in implementing a successful newborn Cystic fibrosis screening program.
- Communications systems and their models: Massachusetts parent compliance with recommended specialty care after positive Cystic fibrosis newborn screening result.
- Sweat testing infants detected by Cystic fibrosis newborn screening.
- Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a Cystic fibrosis newborn screening model demonstrating in...
- Congenital Pulmonary malformations in pediatric patients: review and update on etiology, classification, and imaging findings.
- Cystic fibrosis newborn screening: using experience to optimize the screening algorithm.
- Genetic counseling after implementation of statewide Cystic fibrosis newborn screening: Two years' experience in one medical center.
- Aerosol and lobar administration of a recombinant adenovirus to individuals with Cystic fibrosis. II. Transfection efficiency in airway epithelium.
- Aerosol and lobar administration of a recombinant adenovirus to individuals with Cystic fibrosis. I. Methods, safety, and clinical implications.
- Practice of pediatric pulmonology: results of the Future of Pediatric Education Project (FOPE)
- Immunoprophylaxis with palivizumab, a humanized respiratory syncytial virus monoclonal antibody, for prevention of respiratory syncytial virus infection in high risk i...
- Safety of repeated intermittent courses of aerosolized recombinant human deoxyribonuclease in patients with Cystic fibrosis.
- Interpretation of respiratory input impedance in healthy infants.
- Efficacy of aerosolized tobramycin in patients with Cystic fibrosis.
- Efficacy and safety of short-term administration of aerosolized recombinant human deoxyribonuclease in patients with Cystic fibrosis.
- Consensus conference: practical applications of Pulmozyme. September 22, 1993.
- Multiplex PCR amplification from the CFTR gene using DNA prepared from buccal brushes/swabs.
- Elastin and collagen degradation products in urine of patients with Cystic fibrosis.
- Correction of the Cystic fibrosis defect by gene complementation in human intrahepatic biliary epithelial cell lines.
- Airway area by acoustic reflections measured at the mouth.
- Interaction of oscillatory and unidirectional flows in straight tubes and an airway cast.
- Respiratory system impedance from 4 to 40 Hz in paralyzed intubated infants with respiratory disease.
- CT appearance of the liver in a patient with biliary cirrhosis and Cystic fibrosis.
- Studies on human erythrocyte inorganic pyrophosphatase.
- Undesirable marketing practices in the pharmaceutical industry.
- Inverse modeling of dog airway and respiratory system impedances.
- Human respiratory input impedance from 4 to 200 Hz: physiological and modeling considerations.
- Density dependence of respiratory system impedances between 5 and 320 Hz in humans.
- Respiratory impedance and multibreath N2 washout in healthy, Asthmatic, and cystic fibrosis subjects.
- Expression of normal and Cystic fibrosis phenotypes by continuous airway epithelial cell lines.
- Increased nerve-growth-factor beta-chain cross-reacting material in familial dysautonomia.
- Yersinia enterocolitica septicemia.
- An investigation of some factors affecting levels of erythrocyte inorganic pyrophosphatase activity.
Schools
Johns Hopkins University School Of Medicine
Johns Hopkins Hospital
Chldns Hospital Med Center
Conditions Treated
- Asthma
- Cystic Fibrosis
- Pneumonia
- Pneumonitis (Due to Solids or Liquids)
- View All
Doctors Specialties
- Pediatric Pulmonology
Accepted Insurances
Awards
- America's Top Doctors
- Boston Magazine
- Fellow (FAAP)
- Super Doctor
- Top MD
Education
-
Boston Children's Hospital -
Johns Hopkins University -
Johns Hopkins University School of Medicine
Hospital
-
Boston Children's Hospital
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1427048107 |
| Last Name Of The Provider | DORKIN |
| First Name Of The Provider | HENRY |
| View All |
Similar Doctors
|
|
Dr. Sze M. Tse, MD |
|
|
Dr. Anna T. Labowsky, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ruobing Wang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eliot S. Katz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jane E. Gross, MD |
|
|
Dr. Dawn A. Ericson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Thomas B. Kinane, MB BCH
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hong-Phuong T. Vo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lara C. Bishay, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michele Palella, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Scott A. Schroeder, MD
This Doctor is OpenDoctor Recommended.
|